In addition, numerous evidence has shown that the functional loss of MIG6 is strongly associated with tumor cell growth, proliferation, invasiveness, and resistance to hormonal therapy in various cancers [25, 26, 27, 28]. This evidence concerns the gene ERRFI1 and cancer.